VMG Pharmaceuticals Presentation.

1. May 2009 1
VMG Pharmaceuticals
Corporate Presentation

2. May 2009 2
Disclaimer
Except for the historical information contained herein, statements in this presentation and
the subsequent discussions,which include words or phrases such as “will”, “aim”, “will likely
result”, “would”, “believe”, “may”, “expect”, “will continue”, anticipate”, “estimate”, “intend”,
“plan”, “contemplate”, “seek to”, “future”, “objective”, “goal”, “project”, “should”, “will pursue”
and similar expressions or variations of such expressions may constitute "forward-looking
statements". These forward-looking statements involve a number of risks, uncertainties
and other factors that could cause actual results to differ materially from those suggested
by the forward-looking statements. These risks and uncertainties include, but are not
limited to our ability to successfully implement our strategy, our growth and expansion
plans, obtain regulatory approvals, our provisioning policies, technological changes,
investment and business income, cash flow projections, our exposure to market risks as
well as other risks. VMG Pharmaceuticals does not undertake any obligation to update
forward-looking statements to reflect events or circumstances after the date thereof.

3. May 2009 3
Our Vision
Vision
To make affordable healthcare globally accessible
Mission
To become the preferred marketing partner by offering qualitative
healthcare products and services through a global network
Aspirations 2013
Aspire to have a strong presence in the regulated markets
Gain a significant market share in LRMs
Become the preferred marketing partner for niche products

4. May 2009 4
Our Values
Excellence
Our unequivocal commitment to excellence will ensure the highest quality of
products and services
Integrity
We emphasize on integrity in every aspect of our business and demand the
highest ethical standards from ourselves and whom we work with, thereby
creating an organization that is trusted by its clients and all business
associates
Customer orientation
We will always strive to do what is best for the customer to ensure long
lasting trusted partnerships and customer loyalty
Corporate Social responsibility
We believe it is critical to play an active role in the development of the social
environment and communities that we live and operate in. We will be good
corporate citizens

5. May 2009 5
Overview
Part of VMG Healthcare Products S.A, a global corporation
established in 1998, headquartered at Costa Rica
Offers a wide range of pharmaceutical products
across therapeutic segments
Strong international presence spread across geographies
Strong logistics and regulatory back up systems in India

6. May 2009 6
VMG: Origin
VMG Healthcare Products SA, a distribution company,
was established in Costa Rica in 1998
It has since then grown into a multifaceted, multi product
global corporation
It represents over 200 companies from India, USA,
Europe, China and Latin America
VMG is the second largest distribution company
in Costa Rica
It has a public market share of 14%
Annual turnover in excess of 20 Million USD
Double digit growth year-on-year for the past 4 years

7. May 2009 7
Our Competitive Advantages

8. May 2009 8
Our Business: Product Portfolio
This includes all dosage forms like orals, liquids, syrups, Ointments and injectables
General Pharmaceuticals
Wide range of products including anti infectives, gastro intestinal and
nutritional supplements
Specialty Segments
We offer products in central nervous system, respiratory, cardiovasculars
and diabetes
Niche Products
Robust portfolio of targeted therapies, cytotoxics, hormonals and
immunosuppressants

9. May 2009 9
Our Business: Global Expansion
VMG Healthcare Products, Guatemala
Established in 2005, it provides distribution services of medical
supplies and pharmaceutical products. It represents various
companies from India, China and many other countries.
VMG Healthcare Products Co. Ltd., China
Set up at Ningbo, it is the manufacturing base for medical devices and
supplies. Established in 2004, today, it exports its products to Latin
America, South East Asia, Europe and USA
VMG Pharmaceuticals, Panama
Established in 2006, VMG Panama provides
distribution services, and currently represents
pharmaceutical companies from India and China
Future plans include a foray into medical supplies
segment

10. May 2009 10
Our Business: Global Expansion
VMG Medical, El Salvador
Established in 2008, this company provides
excellent distribution services across the country
VMG Medical, Honduras
Established in 2008 to complete VMG’s
comprehensive distribution network in
central America
VMG Medical, Nicaragua
Established in 2008, the company offers
distribution services across the country

11. May 2009 11
Our Business: Global Expansion
VMG Medical Pty., Australia
Established in 2009 at Sydney, VMG Medical Pty currently offers marketing
and distribution of medical supplies from VMG Denmark and VMG China.
Pharmaceutical products from VMG India are currently under registration.
VMG Denmark APS.
Established in 2008, it marks the first venture in the regulated markets.
VMG Denmark is an ISO certified company and has recently received the
CE certification.
VMG Pharma FZE, UAE
Established in 2008 at the Sharjah Free Zone, It offers a base for expansion
of the Indian operations to Middle East

12. May 2009 12
Our Business: Global Commercialization
Asia Pacific
Recently VMG has tied up alliances with well established distributors in
Thailand, Vietnam, Philippines to represent our interests. Products are
currently under registration. Future plans include expansion into Malaysia, Sri
Lanka, Pakistan and Middle East.
CIS
Currently we have products under registration in
Ukraine and Russia. Future plans include presence in
Kazakhstan, Uzbekistan and Belarus.
Latin America
Apart from having our own distribution network across
Central America, VMG has products under registration
in Guatemala, Costa Rica, Colombia, Venezuela and
the Caribbean.

13. May 2009 13
Our Business: Global Marketing
At VMG, we strive to reach out to the worldwide markets.
In our continuing efforts in this direction, we have participated in
various international conferences like Hospitalar, Brazil and
Medica 2008, Dusselfdorf.

14. May 2009 14
Strategic Initiative
Focus on the rapidly growing generic market
Target regulated and non regulated markets
for balanced growth
Offer products with different delivery and dosage forms
Enter niche markets

15. May 2009 15
World-Class Manufacturing
World-class pharmaceutical products from Oncology,
Anti-infective, Antiretroviral, Cardiovascular, Musculo-
skeletal, Dermatological, Gastrointestinal, Central
Nervous System, Respiratory, Genito-urinary and
Nutritional segments

16. May 2009 16
Commitment to Excellence
Throughout the organization, our teams are working on commercial, functional
and process excellence through continuous improvement in all aspects of our
operations
Commercial Excellence
Creating high-value solutions for our customers with consistent
product quality, reliable delivery and service and distinctive technology
Functional Excellence
Operating at top efficiency to offer cost effective products
Process Excellence
Creating fully integrated systems that enable us to leverage our scale
of distribution and marketing network and build strategic alliances

17. May 2009 17
Commitment to Excellence
“Excellence is an art won by training and habituation.
We are what we repeatedly do.
Excellence then, is not an act, but a habit."
- Aristotle

18. May 2009 18
“He who has health has hope. He who has hope has everything.”